001     144470
005     20240229112626.0
020 _ _ |a 978-1-4939-9150-1 (print)
020 _ _ |a 978-1-4939-9151-8 (electronic)
024 7 _ |a 10.1007/978-1-4939-9151-8_15
|2 doi
024 7 _ |a pmid:30779042
|2 pmid
024 7 _ |a 1064-3745
|2 ISSN
024 7 _ |a 1940-6029
|2 ISSN
024 7 _ |a altmetric:56072597
|2 altmetric
037 _ _ |a DKFZ-2019-01921
041 _ _ |a eng
082 _ _ |a 570
100 1 _ |a Hübschmann, Daniel
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a Evaluation of Whole Genome Sequencing Data.
260 _ _ |a [Heidelberg]
|c 2019
|b [Springer]
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Book
|0 PUB:(DE-HGF)3
|2 PUB:(DE-HGF)
|m book
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1565335613_21515
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Whole genome sequencing (WGS) can provide comprehensive insights into the genetic makeup of lymphomas. Here we describe a selection of methods for the analysis of WGS data, including alignment, identification of different classes of genomic variants, the identification of driver mutations, and the identification of mutational signatures. We further outline design considerations for WGS studies and provide a variety of quality control measures to detect common quality problems in the data.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef Book Series, PubMed,
700 1 _ |a Schlesner, Matthias
|0 P:(DE-He78)f2a782242acf94a3114d75c45dc75b37
|b 1
|e Last author
|u dkfz
773 _ _ |a 10.1007/978-1-4939-9151-8_15
|0 PERI:(DE-600)2493551-7
|p 321-336
|t Methods in molecular biology
|v 1956
|y 2019
|x 1064-3745
909 C O |o oai:inrepo02.dkfz.de:144470
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)f2a782242acf94a3114d75c45dc75b37
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|2 G:(DE-HGF)POF3-300
|v Functional and structural genomics
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
920 1 _ |0 I:(DE-He78)B080-20160331
|k B080
|l Theoretische Bioinformatik
|x 0
920 1 _ |0 I:(DE-He78)V960-20160331
|k V960
|l HI-Stem
|x 1
920 1 _ |0 I:(DE-He78)A010-20160331
|k A010
|l Stammzellen und Krebs
|x 2
920 1 _ |0 I:(DE-He78)B240-20160331
|k B240
|l Bioinformatik und Omics Data Analytics
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a book
980 _ _ |a I:(DE-He78)B080-20160331
980 _ _ |a I:(DE-He78)V960-20160331
980 _ _ |a I:(DE-He78)A010-20160331
980 _ _ |a I:(DE-He78)B240-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21